BioSpace News Archive

Advanced synthetic bioabsorbable solution controls bleeding during sternotomy procedures and promotes bone growth during post-operative healing

Students can enter the workforce in as little as three years, fill urgent regional need

A new study from Housman Institute shows that begin to…ECSEL —an emotional cognitive and social early learning approach for children from birth—quantifiably improves self-regulation, empathy and social-emotional skills that are foundational to emotional intelligence.

Cellular Remote Monitoring Helps Reduce HbA1c Levels in High-Risk Patients by Providing Accurate and Real-Time Blood Glucose Results

Avidity Science launches its golden anniversary with a year-long celebration of achievements and milestones from the past 50 years.

Hollis, who spent his nine-year career with the Jacksonville Jaguars, Buffalo Bills and New York Giants from 1995-2003, saw how much CBD has been circulating in the news lately, and wanted to learn about the benefits and give it a try.

Pulmatrix continues to advance its iSPERSE-based product candidates with a focus on our Pulmazole program that targets fungal infections for severe asthma and cystic fibrosis patients

Healthcare Finance unit served as joint lead arranger and administrative agent on the first-lien credit facility for the acquisition of KabaFusion, a leading provider of acute and specialty home infusion services, by Pritzker Private Capital.

Survey of more than 2,000 beneficiaries also found that most are happy with their Medicare benefits and believe all Americans should have Medicare-like coverage

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced that it will release fourth quarter and full year 2018 financial results after the market closes on Monday, February 25, 2019.